Drug intelligence / Profile preview

cultured autologous mesenchymal cells

Development stage
Unknown
Lead developer
Universidad Autónoma de Madrid
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intralesional
01

Overview

Cultured autologous mesenchymal cells is an investigational advanced therapy medicinal product (ATMP) consisting of autologous bone marrow-derived mesenchymal stem cells (MSCs) expanded ex vivo. Developed by the Universidad Autónoma de Madrid under the leadership of Prof. Enrique Gomez-Barrena, the therapy is designed to treat early-stage avascular necrosis of the femoral head (ONFH). The cells are administered via a single in situ injection into the necrotic area of the femoral head. The mechanism of action involves the promotion of bone healing and regeneration through the osteogenic differentiation of the MSCs into bone-forming cells and the paracrine secretion of growth factors that support tissue repair and revascularization.

Other names
autologous bone marrow-derived mesenchymal stem cellsautologous MSCsbone marrow derived autologous MSCs

Beyond the preview

Go deeper on cultured autologous mesenchymal cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cultured autologous mesenchymal cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call